These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8105562)

  • 1. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
    Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
    J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.
    Ying QL; Simon SR
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastase inhibitors of the respiratory tract.
    Stockley RA; Morrison HM
    Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
    Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
    Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between secretory leukocyte protease inhibitor levels in bronchoalveolar lavage fluid and postoperative pulmonary complications in patients with esophageal cancer.
    Tsukada K; Miyazaki T; Katoh H; Masuda N; Ojima H; Fukuchi M; Manda R; Fukai Y; Nakajima M; Sohda M; Kuwano H
    Am J Surg; 2005 Apr; 189(4):441-5. PubMed ID: 15820457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor in normal, allergic and virus induced nasal secretions.
    Fryksmark U; Jannert M; Ohlsson K; Tegner H; Wihl JA
    Rhinology; 1989 Jun; 27(2):97-103. PubMed ID: 2781219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of granulocytes and antiproteases in open heart surgery].
    Welters ID; Hirsch J; Menzebach A; Hempelmann G; Müller M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):164-72. PubMed ID: 15770560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
    Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
    Rao NV; Marshall BC; Gray BH; Hoidal JR
    Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
    Ohlsson K; Bjartell A; Lilja H
    J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell profile and elastase activity in diffuse panbronchiolitis investigated by bronchoalveolar and bronchial lavage.
    Yasuoka S; Fujisawa K; Ueta Y; Nii Y; Inoue I; Tani K; Ohgushi F; Ogura T
    Intern Med; 1992 May; 31(5):599-605. PubMed ID: 1504421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Tegner H; Fryksmark U; Ohlsson K
    Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.